Financhill
Buy
54

TRVI Quote, Financials, Valuation and Earnings

Last price:
$6.09
Seasonality move :
-6.99%
Day range:
$6.05 - $6.34
52-week range:
$2.36 - $7.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.23x
Volume:
1.1M
Avg. volume:
1.9M
1-year change:
119.86%
Market cap:
$619.6M
Revenue:
--
EPS (TTM):
-$0.45

Earnings Data

Next earnings date for TRVI
Aug 08
2025
Most recent earnings per share
-$0.09
Beat by $0.03
(May 8/2025)
Consensus Estimate
-$0.12
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TRVI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 -- -- -- -$0.10 --
05/08/2025 Q1 -- -- -$0.09 -$0.12 $0.03
03/18/2025 Q4 -- -- -$0.11 -$0.12 $0.01
11/06/2024 Q3 -- -- -$0.13 -$0.11 -$0.02
08/08/2024 Q2 -- -- -$0.12 -$0.11 -$0.01
05/07/2024 Q1 -- -- -$0.11 -$0.09 -$0.02
03/20/2024 Q4 -- -- -$0.08 -$0.09 $0.01
11/09/2023 Q3 -- -- -$0.08 -$0.09 $0.01
08/10/2023 Q2 -- -- -$0.07 -$0.09 $0.02
05/11/2023 Q1 -- -- -$0.06 -$0.07 $0.01
03/16/2023 Q4 -- -- -$0.06 -$0.10 $0.04
11/10/2022 Q3 -- -- -$0.12 -$0.13 $0.01
08/11/2022 Q2 -- -- -$0.14 -$0.19 $0.05
05/12/2022 Q1 -- -- -$0.24 -$0.29 $0.05
03/17/2022 Q4 -- -- -$0.24 -$0.30 $0.06
11/10/2021 Q3 -- -- -$0.34 -$0.40 $0.06
08/12/2021 Q2 -- -- -$0.49 -$0.46 -$0.03
05/13/2021 Q1 -- -- -$0.43 -$0.52 $0.09
03/25/2021 Q4 -- -- -$0.51 -$0.44 -$0.07
11/11/2020 Q3 -- -- -$0.41 -$0.51 $0.10
08/12/2020 Q2 -- -- -$0.41 -$0.48 $0.07
05/07/2020 Q1 -- -- -$0.48 -$0.44 -$0.04
03/16/2020 Q4 -- -- -$0.37 -$0.51 $0.15
11/14/2019 Q3 -- -- -$0.41 -$0.48 $0.07
08/12/2019 Q2 -- -- -$0.41 -$0.42 $0.01
06/13/2019 Q1 -- -- -- -$0.52 --

Trevi Therapeutics Earnings Questions

  • How Much did Trevi Therapeutics Generate in Revenue Last Quarter?

    Trevi Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Trevi Therapeutics Beat Earnings Last Quarter?

    Trevi Therapeutics announced earnings per share of -$0.09 which represents a beat of analyst forecast a -$0.12 per share.

  • Is Trevi Therapeutics Profitable?

    Trevi Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Trevi Therapeutics EPS Next Year?

    Trevi Therapeutics's earnings are forecast to decrease from -$0.47 per share to -$0.43 per share next year representing a decrease of -6.74%.

  • When is Trevi Therapeutics's Earnings Date?

    Trevi Therapeutics's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock